Target intelligence / Profile preview

Bromodomain-containing protein 4 (BRD4)

Target
BRD4
Molecular classification
Transcription factor, Chromatin reader, Epigenetic regulator, BET family
01

Overview

Bromodomain-containing protein 4 (BRD4) is a member of the BET (Bromodomain and Extra-Terminal domain) family of proteins that functions as a chromatin reader. It binds to acetylated lysine residues on histone tails, influencing gene transcription, epigenetic memory, and cell cycle progression. BRD4 plays a crucial role in recruiting transcription factors, regulating RNA polymerase II activity, and maintaining epigenetic information during cell division. Dysregulation of BRD4 is implicated in various diseases, including cancer and inflammatory conditions, making it an important therapeutic target. Inhibitors of BRD4 are currently under clinical investigation for their potential to block cell proliferation and modulate inflammatory responses.

Other names
MCAPMitotic Chromosome Associated ProteinFshrg4Hunk1
02

Mechanism of action

Inhibition of BRD4 binding to acetylated lysine residues on histones, thereby blocking the recruitment of transcription factors and disrupting gene expression.

03

Biological functions

Transcriptional regulationEpigenetic memoryHistone acetyltransferase activityCell cycle progressionCell differentiation
04

Disease associations

CancerNUT midline carcinomaInflammatory diseases
05

Safety considerations

Potential for broad transcriptional effects due to BRD4's role in regulating many genesToxicity related to cell cycle disruption
06

Biomarkers

BRD4 expression levels in tumor tissue (prognostic marker in some cancers)

Beyond the preview

Go deeper on Bromodomain-containing protein 4 (BRD4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bromodomain-containing protein 4 (BRD4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call